Ignite Creation Date:
2025-12-25 @ 12:57 AM
Ignite Modification Date:
2026-03-05 @ 1:05 AM
Study NCT ID:
NCT02352493
Status:
COMPLETED
Last Update Posted:
2020-03-30
First Post:
2015-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH
Sponsor:
Alnylam Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-23
First Submit QC Date:
None
Study First Post Date:
2015-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-01
Results First Submit QC Date:
None
Results First Post Date:
2020-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-17
Last Update Post Date:
2020-03-30
Last Update Post Date Type:
ACTUAL